NOTE: The following Minutes are provided for
informational purposes only. If you would like to obtain an official copy of
these Minutes, please contact the State
Board of Pharmacy at 614/466-4143 for instructions and fee. |
Minutes Of The Meeting
Ohio State Board of Pharmacy
September 11, 12, 2001
TUESDAY, SEPTEMBER 11, 2001
8:00 a.m. ROLL CALL
The State Board of Pharmacy convened in Room 1948, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present:
Ann D. Abele, R.Ph. (President); Diane C. Adelman, R.Ph. (Vice-President); Gregory Braylock, R.Ph.; Robert P. Giacalone, R.Ph.; Lawrence J. Kost, R.Ph.; Nathan S. Lipsyc, R.Ph.; Dorothy S. Teater, Public Member; and James E. Turner, R.Ph.
Also present were William T. Winsley, Executive Director; Timothy Benedict, Assistant Executive Director; William McMillen, Licensing Administrator; Mark Keeley, Legislative Affairs Administrator; David Rowland, Legal Affairs Administrator; Robert Cole, Compliance Supervisor; and Sally Ann Steuk, Assistant Attorney General.
8:05 a.m.
The Board was joined by Assistant Attorney General Sally Ann Steuk for the purpose of conducting an adjudication hearing in accordance with Ohio Revised Code Chapters 119. and 4729. in the matter of Raleigh L. Smith, R.Ph., Waldo.
9:40 a.m.
The hearing ended and the record was closed. The Board took a brief recess.
10:04 a.m.
The Board was joined by Assistant Attorney General Sally Ann Steuk for the purpose of conducting an adjudication hearing in accordance with Ohio Revised Code Chapters 119. and 4729. in the matter of James W. Smetana, R.Ph., West Milton.
11:30 a.m.
The hearing was recessed and continued to a later date due to the emergency declaration issued by the Governor, mandating the evacuation of the building by all non-essential personnel.
11:33 a.m.
After discussion, Mr. Lipsyc moved that the Minutes of the August 6, 7, 8, 2001, Board meeting be approved as amended. The motion was seconded by Mrs. Adelman and approved by the Board (Aye-7/Nay-0).
11:41 a.m.
Mrs. Adelman moved that the Board go into Executive Session for the purpose of the investigation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code. The motion was seconded by Mr. Braylock and a roll call vote was conducted by President Abele as follows: Adelman-Yes, Braylock-Yes, Giacalone-Yes, Lipsyc-Yes, Kost-Yes, Teater-Yes, and Turner-Yes.
11:43 a.m.
RES. 2002-023 The Executive Session ended and the meeting was opened to the public. Mrs. Teater moved that the Board adopt the following Order in the matter of Raleigh L. Smith, R.Ph.:
ORDER OF THE STATE BOARD OF PHARMACY
(Docket
No. D-010514-064)
In
The Matter Of:
RALEIGH L. SMITH, R.Ph.
1686
Newmans Cardington Road East
Waldo,
Ohio 43356
(R.Ph. No. 03-1-10859)
INTRODUCTION
THE MATTER OF RALEIGH L. SMITH CAME FOR HEARING ON
SEPTEMBER 11, 2001 BEFORE THE FOLLOWING MEMBERS OF THE BOARD: ANN D. ABELE, R.Ph. (presiding); DIANE C.
ADELMAN, R.Ph.; GREGORY BRAYLOCK, R.Ph ; ROBERT P. GIACALONE, R.Ph.; LAWRENCE
J. KOST, R.Ph.; NATHAN S. LIPSYC, R.Ph.; DOROTHY S. TEATER, PUBLIC MEMBER; AND
JAMES E. TURNER, R.Ph.
RALEIGH L. SMITH WAS REPRESENTED BY DANIEL L.
CONNOR, AND THE STATE OF OHIO WAS REPRESENTED BY SALLY ANN STEUK, ASSISTANT
ATTORNEY GENERAL.
SUMMARY
OF EVIDENCE
(A) Testimony
State's Witnesses:
(1) None
Respondent's Witnesses:
(1) Donita Smith,
Respondent’s Wife
(2) Stephen Harris, R.Ph.
(3) Raleigh L. Smith, Respondent
(B) Exhibits
State's Exhibits:
(1) Exhibit 1--Hearing Request letter dated May 10, 2001.
(2) Exhibit 1A--Copy of Hearing Schedule letter dated May 14,
2001.
(3) Exhibit 1B--Copy of Ohio Pharmacist computer record of Raleigh
L. Smith.
(4) Exhibit 2--Copy of two-page Statement of Raleigh L. Smith
notarized August 16, 1999.
(5) Exhibit 3--Copy of Wal-Mart Audit for May 1, 1999 through
August 5, 1999.
(6) Exhibit 4--Copy of two-page Indictment in the Marion County
Court of Common Pleas, State of Ohio vs. Raleigh L. Smith aka “Butch”,
Case No. 99-CR-0227, filed September 8, 1999.
(7) Exhibit 5--Copy of two-page Request for Treatment in Lieu of
Conviction in the Marion County Court of Common Pleas, State of Ohio vs.
Raleigh L. Smith, Case No. 99 CR 00227, filed September 22, 1999.
(8) Exhibit 6--Copy of Indictment in the Marion County Court of
Common Pleas, State of Ohio vs. Raleigh L. Smith aka “Butch”, Case No.
00-CR-0046, filed February 24, 2000.
(9) Exhibit 7--Copy of six-page Judgment Entry of Sentencing in
the Marion County Court of Common Pleas, State of Ohio vs. Raleigh L. Smith
aka “Butch”, Case No. 00-CR-046, filed June 9, 2000.
(10) Exhibit 8--Copy of two-page letter from
Marion County Assistant Prosecuting Attorney Rhonda G. Burggraf dated June 29,
2000; Copy of Ohio Board of Pharmacy Offense Report for Raleigh “Butch” Smith;
Copy of six-page Judgment Entry of Sentencing in the Marion County Court of
Common Pleas, State of Ohio vs. Raleigh L. Smith aka “Butch”, Case No.
00-CR-046, filed June 3, 2000.
(11) Exhibit 9--Copy of seven-page Order of the
State Board of Pharmacy, Docket No. D-990908-017 in the matter of Raleigh L.
Smith, R.Ph. dated September 11, 2000.
Respondent's Exhibits:
(1) Exhibit A--Copy of two-page PRO Inc. Recovering Pharmacist’s
Contract of Raleigh L. Smith dated October 1, 2000; Copy of seven-page Order of
the State Board of Pharmacy, Docket No. D-990908-017 in the matter of Raleigh
L. Smith, R.Ph. dated September 11, 2000; Copy of a table listing continuing
pharmacy education programs dated between January 16, 2000 and April 29, 2001
totaling 8.7 CEUs; Seventeen pages of copies of continuing pharmacy education
certificates dated between January 16, 2000 and April 29, 2001; Copy of
Cashier’s Check No. 262623 payable to Marion County Clerk of Courts in the
amount of $21,326.88 dated January 20, 2001, and Marion County Common Pleas
Court Receipt No. 114204 dated January 23, 2001; Copy of twenty-three pages of
drug screen reports of Raleigh Smith for samples collected July 6, 2000, August
21, 2000, September 20, 2000, October 17, 2000, November 7, 2000, December 6,
2000, January 5, 2001, January 19, 2001, February 13, 2001, March 12, 2001,
April 20, 2001, April 27, 2001, May 26, 2001, June 22, 2001, July 21, 2001, and
August 6, 2001; Copy of sixteen pages of support meeting attendance
verification sheets of Butch Smith dated August 1, 2000 through August 16,
2001; Letter from Dean Dibling, Marion County Adult Probation Department, dated
August 13, 2001; Letter from Jerome E. Driesen, M.D. dated August 15, 2001;
Copy of letter from Stephen D. Harris, R.Ph. dated August 16, 2001; Letter from
Richard A. Kryc, R.Ph. dated August 9, 2001; Letter from Charlie Broussard,
R.Ph. dated August 6, 2001.
(2) Exhibit B--Copy of Quest Diagnostics Incorporated drug screen
report of Raleigh Smith for sample collected September 3, 2001.
(3) Exhibit C--Personal Data of Raleigh L. Smith, not dated;
Two-page copy of PRO, Inc. Pharmacist’s Recovery Contract of Raleigh Smith
dated September 12, 1999; Copy of Harding Addiction Recovery Center Continuing
Care Treatment Agreement of Raleigh Smith dated September 14, 1999; Copy of
letter from Connor & Behal L.L.P. dated February 14, 2000; Copy of letter
from Gayle L. Diehl dated February 28, 2000; Copy of Harding Hospital Chart of
Raleigh Smith consisting of 105 pages dated from August 24, 1999, through
September 14, 1999; Copy of four letters from Gayle L. Diehl dated February 28,
2000, July 31, 2000, December 28, 1999, and June 22, 2000; Copy of letter from
Patricia Kijewski dated April 5, 2000; Copy of letter from Stephen D. Harris
dated July 18, 2000; Copy of twenty-four pages of drug screen reports of
Raleigh Smith for samples collected August 26, 1999, August 27, 1999, September
1, 1999, September 3, 1999, September 10, 1999, September 21, 1999, October 7,
1999, October 8, 1999, October 28, 1999, November 22, 1999, December 13, 1999,
January 25, 2000, February 22, 2000, March 21, 2000, April 20, 2000, May 17,
2000, June 13, 2000, and July 6, 2000; Affidavit of Jerome Driesen, M.D.
notarized on July 27, 2000; Copy of twenty pages of support meeting attendance
verification sheets of Raleigh L. Smith dated from August 31, 1999, through
July 31, 2000; Two Certificates of Appreciation of Raleigh Smith dated December
31, 1999, and April 28, 2000; page 6 of the Prospective,
not dated; pages 1 and 3 of the Prospective,
Volume 4, Issue 3, dated July, 2000; unnumbered page of the Prospective, dated Summer 2000; and copy
of two-page Presby Press, dated May,
2000; Eighteen pages of copies of continuing pharmacy education certificates
dated between January 16, 2000, through June 23, 2000; Letter from Gerggory (sic)
P. Musson dated July 24, 2000; Two-page letter from Lesley, not dated;
two-page letter from Donita K. Smith dated July 17, 2000; two-page letter from
Nancy K. (Smith) Eaves dated July 27, 2000; and two-page letter from Jeffrey L.
Smith dated August 1, 2000; Letter from Susan E. Perry dated July 6, 2000, and
letter from Carol E. Grant, not dated; Letter from Jerome E. Driesen dated July
27, 2000; letter form Stephen D. Harris dated February 20, 2000; letter from
Richard A. Kryc dated February 15, 2000; letter from Todd R. Jaros dated July
6, 2000; letter from Tracey Merrin dated August 2, 2000; letter from Gerald W.
Reed dated July 31, 2000; and letter from Mary B. dated July 3, 2000.
(4) Exhibit D--Copy of seventeen pages of drug screen reports of
Raleigh Smith for samples collected August 21, 2000, September 20, 2000,
October 17, 2000, November 7, 2000, December 6, 2000, January 5, 2001, January
19, 2001, February 13, 2001, March 12, 2001, April 13, 2001, April 20, 2001,
April 27, 2001, May 26, 2001, June 22, 2001, July 21, 2001, and August 6, 2001.
FINDING
OF FACT
After having heard the testimony, observed the demeanor
of the witnesses, considered the evidence, and weighed the credibility of each,
the State Board of Pharmacy finds Raleigh L. Smith has complied with the terms
set forth in the Order of the State Board of Pharmacy, Docket No. D-990908-017,
effective September 11, 2000.
ACTION
OF THE BOARD
On the basis of the Finding of Fact set forth above,
the State Board of Pharmacy hereby approves the reinstatement of the pharmacist
identification card, No. 03-1-10859, held by Raleigh L. Smith to practice
pharmacy in the state of Ohio and places Mr. Smith on probation for five years
from the date the identification card is issued, with the following conditions:
(A) Raleigh L. Smith must enter into a contract, signed within
thirty days after the effective date of this Order, with an Ohio Department of
Alcohol and Drug Addiction Services (ODADAS) treatment provider or a treatment
provider acceptable to the Board for a period of not less than five years and
submit a copy of the signed contract to the Board office with the renewal
application. The contract must provide
that:
(1) Random, observed urine drug screens shall be conducted at least once
every three months.
(a) The urine sample must be given within twelve hours of notification. The urine drug screen must include testing
for creatinine or specific gravity of the sample as the dilutional standard.
(b) Hydrocodone must be added to the standard urine drug screen.
(c) Results of all drug screens must be negative. Any positive results, including those which
may have resulted from ingestion of food, but excluding false positives which
resulted from medication legitimately prescribed, indicates a violation of the
contract and probation.
(2) The
intervener/sponsor shall provide copies of all drug screen reports to the Board
in a timely fashion.
(3) Attendance
is required a minimum of three times per week at an Alcoholics Anonymous,
Narcotics Anonymous, and/or similar support group meeting.
(4) The
program shall immediately report to the Board any violations of the contract
and/or lack of cooperation.
(B) Raleigh L. Smith must submit quarterly progress reports to the
Board (due January 10, April 10, July 10, and October 10 of each year of
probation) that include:
(1) The
written report and documentation provided by the treatment program pursuant to
the contract, and
(2) A
written description of Raleigh L. Smith 's progress towards recovery and what
Raleigh L. Smith has been doing during the previous three months.
(C) Other terms of probation are as follows:
(1) The
State Board of Pharmacy hereby declares that Raleigh L. Smith's pharmacist
identification card is not in good standing and thereby denies the privilege of
being a preceptor and training pharmacy interns pursuant to paragraph (D)(1) of
Rule 4729-3-01 of the Ohio Administrative Code.
(2) Raleigh
L. Smith may not serve as a responsible pharmacist.
(3) Raleigh
L. Smith may not destroy, assist in, or witness the destruction of controlled
substances.
(4) Raleigh
L. Smith must abide by the contract from the treatment provider and any
violation must be reported to the Board immediately.
(5) Raleigh
L. Smith must not violate the drug laws of the State of Ohio, any other state,
or the federal government.
(6) Raleigh
L. Smith must abide by the rules of the State Board of Pharmacy.
(7) Raleigh
L. Smith must comply with the terms of this Order.
Raleigh L. Smith is hereby advised that the Board
may at any time revoke probation for cause, modify the conditions of probation,
and reduce or extend the period of probation.
At any time during this period of probation, the Board may revoke
probation for a violation occurring during the probation period.
THIS ORDER WAS
APPROVED BY A VOTE OF THE STATE BOARD OF PHARMACY.
MOTION CARRIED.
SO ORDERED.
The motion was seconded by Mr. Turner and approved by the Board (Aye-7/Nay-0).
11:45 a.m.
The rest of the scheduled business for the day was postponed until a later date and the meeting was recessed until Wednesday, September 12, 2001.
wednesday, september 12, 2001
8:00 a.m. ROLL CALL
The State Board of Pharmacy reconvened in Room 1948, Vern Riffe Center for Government and the Arts, 77 South High Street, Columbus, Ohio with the following members present:
Ann D. Abele, R.Ph. (President); Robert P. Giacalone, R.Ph.; Lawrence J. Kost, R.Ph.; Nathan S. Lipsyc, R.Ph.; Dorothy S. Teater, Public Member; and James E. Turner, R.Ph.
8:07 a.m.
Mr. Benedict discussed the Maryhaven request that had been tabled during the August meeting with the Board. Mr. Benedict announced that, due to a change in the procedure at Maryhaven, a request for a waiver from the requirements of Administrative Code Rule 4729-5-10 was no longer needed and the request was, therefore, being withdrawn.
Mr. Benedict then presented a request from Richard Gulling, R.Ph. asking for a waiver from the requirements of Administrative Code Rule 4729-5-11(A) to allow him to serve as responsible pharmacist at more than one location. After discussion, the request was tabled pending receipt of further information.
RES. 2002-024 Mr. Benedict next presented a request from Ron Ferguson, R.Ph. asking for a waiver from the requirements of Administrative Code Rule 4729-5-11(A) to allow him to serve as responsible pharmacist at more than one location. After discussion, Mr. Giacalone moved that the request be approved until the sale is made or for six months, whichever comes first, at the following two locations:
Stoudt Pharmacy (02-0654600)
Mt. Orab Pharmacy (02-1102600)
The motion was seconded by Mr. Turner and approved by the Board (Aye-5/Nay-0).
RES. 2002-025 Mr. Benedict presented a request from Robert Chandler asking for a waiver from the requirements of Administrative Code Rule 4729-5-11(A) to allow him to serve as responsible person at more than one location. After discussion, Mr. Kost moved that the request be approved until the opening of the new site at the following two locations:
University Hosp. Cleveland PET Lab (02-111100)
Cyclo-Tech LLC (New Application)
The motion was seconded by Mr. Lipsyc and approved by the Board (Aye-5/Nay-0).
RES. 2002-026 Mr. Keeley then presented a request from the American Pharmaceutical Association (APhA) for approval of the immunization courses offered by them over the last several years. After a discussion of Mr. Keeley’s review of the materials presented by APhA, Mr. Kost moved that the Board approve the courses in pharmacist administration of immunizations that were conducted by the APhA from 1999 to the present. The motion was seconded by Mr. Turner and approved by the Board (Aye-5/Nay-0).
8:20 a.m.
Board Member Gregory Braylock, R.Ph. arrived.
8:23 a.m.
RES. 2002-027 After obtaining more information, the Board again reviewed the request from Richard Gulling R.Ph. asking for a waiver from the requirements of Administrative Code Rule 4729-5-11(A) to allow him to serve as responsible pharmacist at more than one location. After discussion, Mr. Turner moved that the request be approved for one year at the following two locations:
Samaritan LTC Pharmacy (02-0978350)
Samaritan Pharmacy at Maria Joseph(02-978400)
The motion was seconded by Mr. Lipsyc and approved by the Board (Aye-6/Nay-0).
RES. 2002-028 Mr. Lipsyc and Mr. McMillen discussed two requests from groups wishing to be approved as providers of continuing pharmacy education (CPE) by the Board. After discussion, Mr. Lipsyc moved that the Board approve the application presented by Holzer Medical Center Pharmacy/Gallipolis to be a provider of continuing pharmacy education. The motion was seconded by Mr. Turner and approved by the Board (Aye-6/Nay-0).
RES. 2002-029 Mr. Lipsyc then moved that the Board approve the application presented by the Drake Center, Inc./Cincinnati to be a provider of continuing pharmacy education. The motion was seconded by Mr. Turner and approved by the Board (Aye-6/Nay-0).
8:38 a.m.
Board Member Diane Adelman, R.Ph. arrived and joined the meeting in progress.
RES. 2002-030 Mr. Benedict presented a request from Steven Salo, R.Ph. that the Board reconsider the prohibition in his Board Order against working in a licensed location so that he could attend school to become a physical therapy assistant. After discussion, Mrs. Teater moved that the Board deny the request. The motion was seconded by Mr. Turner and approved by the Board (Aye-7/Nay-0).
Mr. Keeley presented his Legislative Report to the Board.
There was no report on the Medical Board Prescribing Committee to be presented.
Mr. Kost reported that the Nursing Board Committee on Prescriptive Governance would be meeting the week of September 17.
Ms. Abele reported that the next Nursing Board Formulary Committee meeting was scheduled for October 15th.
Mr. Winsley announced that the Board office would soon be sending out a Compliance Bulletin due to the announcement by the Drug Enforcement Administration (DEA) that Midrin® and other products containing dichloralphenazone were now Schedule IV controlled substances.
8:52 a.m.
RES. 2002-031 Mr. Kost moved that the Board recognize William Kelley, R.Ph. on the retirement of his license to practice pharmacy. The motion was seconded by Mr. Turner and approved by the Board (Aye-7/Nay-0).
8:56 a.m.
The Board took a brief recess.
9:09 a.m.
The Board was joined by Assistant Attorney General Sally Ann Steuk for the purpose of conducting an adjudication hearing in accordance with Ohio Revised Code Chapters 119. and 4729. in the matter of Karen E. Martin, R.Ph., Lebanon.
10:14 a.m.
The hearing ended and the record was closed. The Board took a brief recess.
10:27 a.m.
RES. 2002-032 Mr. Lipsyc moved that, due to the unusual circumstances that occurred on Tuesday, the Board approve a special reciprocity meeting to be held by the Board staff for those reciprocity candidates who were scheduled to appear before the Board on Tuesday, September 11, 2001, and that these candidates be awarded their pharmacist identification cards upon the successful completion of that meeting. Furthermore, Mr. Lipsyc moved that Board staff should report the names of the successful reciprocity candidates to the Board at the next meeting of the Board. The motion was seconded by Mr. Giacalone and approved by the Board (Aye-7/Nay-0).
10:29 a.m.
Mrs. Adelman moved that the Board go into Executive Session for the purpose of the investigation of complaints regarding licensees and registrants pursuant to Section 121.22(G)(1) of the Revised Code. The motion was seconded by Mrs. Teater and a roll call vote was conducted by President Abele as follows: Adelman-Yes, Braylock-Yes, Giacalone-Yes, Lipsyc-Yes, Kost-Yes, Teater-Yes, and Turner-Yes.
10:55 a.m.
RES. 2002-033 The Executive Session ended and the meeting was opened to the public. Mr. Braylock moved that, pursuant to Section 3719.121 of the Revised Code, the Board summarily suspend the license to practice pharmacy belonging to Ralph Homer, R.Ph. (03-2-09922) due to the fact that a continuation of his professional practice presents a danger of immediate and serious harm to others. The motion was seconded by Mr. Lipsyc and approved by the Board (Aye-7/Nay-0).
RES. 2002-034 Mr. Kost then moved that the Board adopt the following Order in the matter of Karen E. Martin, R.Ph.:
ORDER OF THE STATE BOARD OF PHARMACY
(Docket
No. D-010313-050)
In
The Matter Of:
KAREN E. MARTIN, R.Ph.
1757
Phillips Road
Lebanon,
Ohio 45036
(R.Ph. No. 03-1-14807)
INTRODUCTION
THE MATTER OF KAREN E. MARTIN CAME FOR HEARING ON
SEPTEMBER 12, 2001 BEFORE THE FOLLOWING MEMBERS OF THE BOARD: ANN D. ABELE, R.Ph. (presiding); DIANE C.
ADELMAN, R.Ph.; GREGORY BRAYLOCK, R.Ph.; ROBERT P. GIACALONE, R.Ph.; LAWRENCE
J. KOST, R.Ph.; NATHAN S. LIPSYC, R.Ph.; DOROTHY S. TEATER, PUBLIC MEMBER; AND
JAMES E. TURNER, R.Ph.
KAREN E. MARTIN WAS REPRESENTED BY DAVID L. KERR,
AND THE STATE OF OHIO WAS REPRESENTED BY SALLY ANN STEUK, ASSISTANT ATTORNEY
GENERAL.
SUMMARY
OF EVIDENCE
(A) Testimony
State's Witnesses:
(1) Robert Burdick, R.Ph., Ohio State Board of Pharmacy
Respondent's Witnesses:
(1) Karen E. Martin, Respondent
(B) Exhibits
State's Exhibits:
(1) Exhibit 1--Copy of Notice of Opportunity for Hearing letter
dated March 13, 2001.
(2) Exhibit 1A--Hearing Request letter dated March 21, 2001.
(3) Exhibit 1B--Copy of Hearing Schedule letter dated March 23,
2001.
(4) Exhibit 1C--Copy of Ohio Pharmacist computer record of Karen
Elaine Martin.
(5) Exhibit 2--Copy of Statement of Karen
Martin notarized on July 27, 2000.
(6) Exhibit 3--Copy of Statement of Cynthia Chopp notarized on July 27, 2000.
(7) Exhibit 4--Copy of CVS Prescription No.
29971500 dated June 21, 1999.
(8) Exhibit 5--Copy of CVS/pharmacy computer-generated page of
labels and customer receipt for Prescription No. 37785600 dated May 19, 2000;
Copy of CVS/pharmacy Prescription No. 9105312 dated March 4, 2000, and
information printout for Prescription
No. 37785600 dated May 19, 2000.
(9) Exhibit 6--Copy of letter from Marshall C. Wareham, MD, FACS
dated August 15, 2001.
(10) Exhibit 7--Copy of two-page letter from
James D. Ruppert dated August 28, 2001.
Respondent's Exhibits:
(1) Exhibit A1--Two-page letter from Karen E. Martin, PharmD dated
February 27, 2001.
(2) Exhibit A2--Two-page handwritten letter from Charles M. Neu,
R.Ph. dated August 25, 2001.
(3) Exhibit A2a--Typed letter from Charles M. Neu, R.Ph. dated
August 25, 2001.
(4) Exhibit A3--Letter from James E. Henderson, R.Ph. dated August
12, 2001.
(5) Exhibit A4--Letter from Deacon Ned Ostendorf dated August 13,
2001.
FINDINGS
OF FACT
After having heard the testimony, observed the
demeanor of the witnesses, considered the evidence, and weighed the credibility
of each, the State Board of Pharmacy finds the following to be fact:
(1) Records of the State Board of Pharmacy indicate that Karen E.
Martin was originally licensed in the state of Ohio on August 6, 1982,
pursuant to examination, and is currently licensed to practice pharmacy in the
state of Ohio.
(2) Karen E. Martin did, on or about May 19, 2000, sell a drug that was misbranded, to wit:
having prescription number 377856 for Trusopt, an ophthalmic solution to
relieve ocular pressure, Karen E. Martin dispensed TobraDex, an ophthalmic
steroidal suspension. The patient
required surgery and suffered permanent sight loss. Such conduct is in violation of Section 3715.52 of the Ohio
Revised Code
CONCLUSION OF LAW
The State Board of Pharmacy concludes that paragraph
(2) of the Findings of Fact constitutes being guilty of violating, conspiring
to violate, attempting to violate, or aiding and abetting the violation of
provisions of Sections 3715.52 to 3715.72 of the Revised Code as provided in
Division (A)(5) of Section 4729.16 of the Ohio Revised Code.
ACTION
OF THE BOARD
Pursuant to Section 4729.16
of the Ohio Revised Code, and on the basis of the Findings of Fact and
Conclusion of Law set forth above, the State Board of Pharmacy hereby imposes
on Karen E. Martin a monetary penalty of two hundred fifty dollars due and
owing within thirty days of the mailing of this Order. The remittance should be made payable to the
“Treasurer, State of Ohio” and mailed with the enclosed form to the State Board
of Pharmacy, 77 South High Street, Room 1702, Columbus, Ohio 43215-6126.
THIS ORDER WAS
APPROVED BY A VOTE OF THE STATE BOARD OF PHARMACY.
MOTION CARRIED.
SO ORDERED.
The motion was seconded by Mr. Braylock and approved by the Board (Aye-7/Nay-0).
11:02 a.m.
Mrs. Adelman moved that the Board receive Per Diem as follows:
PER DIEM |
07/05 |
07/06 |
09/10 |
09/11 |
09/12 |
Total |
Abele |
- |
- |
1 |
1 |
1 |
3 |
Adelman |
- |
- |
- |
1 |
1 |
2 |
Braylock |
- |
1 |
|
1 |
1 |
3 |
Eastman |
- |
- |
- |
- |
- |
0 |
Giacalone |
- |
- |
- |
1 |
1 |
2 |
Lipsyc |
1 |
- |
- |
1 |
1 |
3 |
Kost |
- |
- |
- |
1 |
1 |
2 |
Teater |
- |
- |
- |
1 |
1 |
2 |
Turner |
- |
- |
- |
1 |
1 |
2 |
The motion was seconded by Mr. Lipsyc and approved by the Board (Aye-7/Nay-0).
11:03 a.m.
Mrs. Teater moved that the meeting be adjourned so that the Board members could attend the Annual Licensure Ceremony at Villa Milano beginning at Noon. The motion was seconded by Mr. Turner and approved (Aye-7/Nay-0).
THE BOARD APPROVED THESE MINUTES ON OCTOBER
1, 2001. |